FdaApplication
NDA 205425
Identifiers
- fda_app_no: NDA205425
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LTD |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LOPINAVIR AND RITONAVIR | LOPINAVIR; RITONAVIR | 40MG;10MG | PELLETS;ORAL |
1 product